Categories
Tags
Authors: Brown JT, Saigal A, Karia N, Patel RK, Razvi Y, Steeden JA PMID: 35470679 PMCID: PMC9238618 DOI: 10.1161/JAHA.121.024207 Abstract Background Ongoing exercise intolerance of unclear cause following COVID-19 infection is well recognized but poorly understood. We investigated exercise capacity in patients previously hospitalized with COVID-19 with and without self-reported exercise [...]
Categories: I-RECOVER Post-Vaccine
Tags: COVID-19
Auhtors: Bischoff-Ferrari HA, Willett WC, Manson JE, Dawson-Hughes B, Manz MG, Theller R, et al. PMID: 35821820 PMCID: PMC9261319 DOI: 10.3389/fragi.2022.852643 Abstract Objective: The aim of this study was to test the individual and combined benefit of vitamin D, omega-3, and a simple home strength exercise program on the risk of any invasive cancer. Design: [...]
Categories: Cancer Care
Authors: Burakgazi AZ PMID: 35702058 PMCID: PMC9149535 doi: 10.1159/000524205 Abstract COVID-19 has caused several neurological complications by affecting the central and peripheral nervous systems (PNS). Studies on the PNS involvement in COVID-19 are limited. These complications are likely unreported, given the difficulty of obtaining further diagnostic information, such as expert neurologist evaluation, electrodiagnostic testing, and [...]
Categories: I-RECOVER Post-Vaccine
Tags: COVID-19, Small-Fiber Neuropathies
Authors: Seneff S, Nigh G, Kyriakopoulos AM, McCullough PA PMID: 35436552 PMCID: PMC9012513 DOI: 10.1016/j.fct.2022.113008 Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease has no precedent. The many alterations in the vaccine mRNA hide [...]
Categories: I-RECOVER Post-Vaccine
Tags: SARS-CoV-2 mRNA Vaccines
Auhtors: Seneff S, Nigh G, Kyriakopoulos AM, McCullough PA PMID: 35436552 PMCID: PMC9012513 DOI: 10.1016/j.fct.2022.113008 Abstract The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the context of infectious disease has no precedent. The many alterations in the vaccine mRNA hide [...]
Categories: Cancer Care
Tags: SARS-CoV-2 mRNA Vaccines
Authors: Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W DOI: 10.1056/NEJMoa2118542 Abstract BACKGROUND Nirmatrelvir is an orally administered severe acute respiratory syndrome coronavirus 2 main protease (Mpro) inhibitor with potent pan–human-coronavirus activity in vitro. METHODS We conducted a phase 2–3 double-blind, randomized, controlled trial in which symptomatic, [...]
Categories: I-CARE Early Covid
Tags: COVID-19, nirmatrelvir
Auhtors: Inchauspe J. Abstract USA TODAY BESTSELLER * WALL STREET JOURNAL BESTSELLER * INSTANT INTERNATIONAL BESTSELLER Improve all areas of your health—your sleep, cravings, mood, energy, skin, weight—and even slow down aging with easy, science-based hacks to manage your blood sugar while still eating the foods you love. Glucose, or blood sugar, is a tiny [...]
Categories: Cancer Care
Tags:
The Omicron SARS-CoV-2 variant is responsible for a major wave of COVID-19, with record case counts reflecting high transmissibility and escape from prior immunity. Defining the time course of Omicron viral proliferation and clearance is crucial to inform isolation protocols aiming to minimize disease spread.
Categories:
Tags: COVID-19, Omicron, SARS-CoV-2, viral infection
Auhtors: Lindqvist PG, Epstein E, Landin-Olsson M PMID: 35346986 DOI: 10.21873/anticanres.15644 Abstract There are carcinogenic effects of sun exposure that increase the risk for skin cancer, especially for fair-skinned individuals. Therefore, there are recommendations to avoid sun exposure and to apply sun blockers. A more nuanced and balanced message for sun safety guidelines is now [...]
Categories: Cancer Care
Tags: Sun Exposure
Authors: Lee TC, Vigod S, Hanula R, Boulware DR, Lenze EJ PMID: 35385087 PMCID: PMC8987902 DOI: 10.1001/jamanetworkopen.2022.6269 Abstract Importance: Widely available and affordable options for the outpatient management of COVID-19 are needed, particularly for therapies that prevent hospitalization. Objective: To perform a meta-analysis of the available randomized clinical trial evidence for fluvoxamine in the outpatient [...]
Categories: I-CARE Early Covid
Tags: